

Afobazole pills:
1 pill contains Afobazole 5 or 10 mg;
Excipients: potato starch, MCC, lactose, povidone, Magnesium stearate;
60 pcs. packaged.
Afobazole - a derivative of 2-mercaptobenzimidazole, selective anxiolytic, not belonging to the class of benzodiazepine receptor agonists. Interferes with the development of membrane-dependent changes in the GABA receptor.
It has anxiolytic (anti-anxiety) effect and a light stimulating (activating) effect. It does not have a hypno-sedative effect (sedative effect is manifested in doses 40-50 times higher than the ED50 for anxiolytic action).
Reduction or elimination of anxiety (anxiety, premonitions, apprehension, irritability), tension (fearfulness, tearfulness, anxiety, inability to relax, insomnia, fear), somatic (muscle, sensory, cardiovascular, respiratory, gastrointestinal symptoms), vegetative (dry mouth, sweating, dizziness), cognitive (difficulty concentrating, impaired memory) disorders observed at 5-7 days of treatment with Afobazole. The maximum effect is achieved by the end of 4 weeks of treatment and lasts for an average of 1–2 weeks.
The drug has no muscle relaxant properties, a negative effect on memory and attention.
When using the drug is not formed drug dependence and does not develop withdrawal syndrome.
Afobazole is non-toxic (LD50 in rats is 1.1 g with an ED50 of 1 mg).
Especially shown to persons with predominantly asthenic personality traits in the form of anxious suspiciousness, insecurity, increased vulnerability and emotional lability, a tendency to emotional and stressful reactions.
Afobazole is used in adults with anxiety: generalized anxiety disorders, neurasthenia, adjustment disorders, in patients with various somatic diseases (bronchial asthma, irritable bowel syndrome, systemic lupus erythematosus, coronary heart disease, hypertension, arrhythmias), dermatological, oncological, etc. diseases. In the treatment of sleep disorders associated with anxiety, neurocirculatory dystonia, premenstrual syndrome, absinous alcohol syndrome, to alleviate the withdrawal syndrome with quitting smoking.
Pregnancy, lactation. Individual intolerance to the drug. Children's age up to 18 years.
It is applied inside after eating. The optimal single dose of the drug - 10 mg daily - 30 mg, divided into 3 doses during the day. The duration of the course of the drug is 2-4 weeks.If necessary, the daily dose of the drug can be increased to 60 mg, and the duration of treatment up to 3 months.
Increased individual sensitivity, possible allergic reactions.
Store in a dark place at a temperature not exceeding 25 ° C.
Afobazole